PROM1 and glioblastoma: It was found that stem cell-like CD133/PROM1HIGH patient-derived GBM cells displayed enhanced glucose uptake, as measured by intake of the fluorescent glucose analog 2-NBDG, as compared to non-stem-like CD133/PROM1LOW patient-derived GBM cells (p < 0.05; Fig. 2c).